Removing APIs, antibiotics and EDCs from pharmaceutical wastewater by Arvia Technology скачать в хорошем качестве

Removing APIs, antibiotics and EDCs from pharmaceutical wastewater by Arvia Technology

This video from Arvia Technology (www.arviatechnology.com), explains what we are doing to help the pharmaceutical industry with wastewater pollution. In particular, we discuss how our technology removes APIs (Active Pharmaceutical Ingredients), antibiotics and EDCs (Endocrine-Disrupting Chemicals) from water. The highlights of our Nyex water technology are: • Consistent removal rates maintained • Low energy and low maintenance, so low OpEx • No waste products so incineration is avoided. Our clients tell us that there are two main areas of pharmaceuticals in wastewater that are problematic: • AMR (as a result of exposure of antibiotics to the environment via manufacturing process discharge or via patient vectoring) • EDCs (specific chemicals which need to be removed from lab waste and for larger flows from production waste.) One of the new ‘chemicals of emerging concern’ is Triton X-100, which has endocrine disrupting (EDC) properties. Triton X-100 is banned from waste discharge from November 2021. It is a commonly used disinfectant and cell wall disruptor used extensively in pharmaceutical intermediate production. We can treat wastewater to destroy Triton-x-100. Removing APIs, antibiotics and chemicals like Triton X-100 from water is what we do best. Like most APIs, Triton X-100 adsorbs well onto our media, and once adsorbed, we can oxidise Triton X-100 without it degrading to 4-tert-OPnEO. The advantage our tech has over competing technology is the fact we completely destroy the organics after adsorbing them. So: • Low OpEx - much cheaper than incineration • No toxic waste – eco-friendly and less maintenance • No offsite regeneration required • No sludge generation • Consistent removal rates Our water technology oxidises to very low levels of specific contaminants. An example talked about in this video is sulfamethoxazole, a generic antibiotic, frequently prescribed to treat a wide range of bacterial infections. As with any human prescription, a percentage of the drug passes through our bodies and into the wastewater system, where, as a man-made molecule, biological treatment systems cannot metabolise it. As a result, like many other man-made medicines sulfamethoxazole is gradually increasing in concentration in our water system. It is present at a few micrograms per litre in our water and it shouldn’t be! This is one contributory factor to AMR, as naturally occurring bacteria in our water systems build up a resistance to the drugs in their local environment reducing the effectiveness of the drug in human treatment. In a range of tests on wastewater from all across Europe, we have successfully removed sulfamethoxazole from inlet concentrations ranging from 1μg/L to 0.5μg/L down to less than 0.01μg/L, showing between 90% to 99% removal of the compound from the environment. If you want us to treat your water, just give us a shout. Further details on https://www.arviatechnology.com/